EUVIMEDEUVIMED entdecken
Crossref

An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes

Tal Schiller iD, Linoy Gabay, Oren Barak, Alena Kirzhner iD, Haitham Abu Khadija, Gabriel Chodick, Edi Vaisbuch, Yael Barer

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Tal Schiller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Diabetes and Metabolic Disease, Wolfson Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University,…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Marom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adherence to screening following a pregnancy with gestational diabetes mellitus (GDM) remains low.

Objective

To assess the risk of future type 2 diabetes (T2D) based on the number and type of abnormal results of a 100-gram oral glucose tolerance test (OGTT) performed during pregnancy.

Methods

This retrospective study used data from a major Israeli healthcare provider. Women aged 20 to 50 years without a prior diagnosis of T2D who had a complete 100-gram OGTT during their last pregnancy between January 2000 and December 2022 were included. The primary outcome was the development of T2D by September 2024. Risk was assessed using Cox proportional hazards models based on the number and type of abnormal OGTT values.

Results

The study included 107 889 women (age 34.1 ± 5.2 years; BMI 27.6 ± 5.3 kg/m2). Median follow-up was 6.7 years (IQR 3.3-12.4), totaling 900 000 person-years. T2D developed in 4500 women (0.5%). When compared to women with all OGTT values normal, the risk of T2D rose with each additional abnormal value: hazard ratio (HR) 3.45 (95% CI: 3.15-3.77) for 1 abnormal value, 4.03 (3.69-4.41) for 2 abnormal values, 7.15 (6.49-7.88) for 3, and 10.60 (9.28-12.20) for 4. Abnormal fasting glucose was associated with a higher risk (HR 5.28; 95% CI: 4.83-5.76) than abnormal nonfasting values (HR 3.03; 95% CI: 2.78-3.29). A previous diagnosis of GDM was significantly associated with future T2D risk, even in patients with no current abnormal OGTT values.

Conclusion

The number and type of abnormal OGTT results strongly predict future T2D. These findings can inform targeted postpartum interventions and predictive tools for early prevention in high-risk women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalDiabetes Mellitus, Type 2HumansFemaleGlucose Tolerance TestPregnancyAdultRetrospective StudiesMiddle AgedIsraelBlood GlucoseYoung AdultRisk FactorsFollow-Up StudiesPredictive Value of TestsPrognosis

Stichwörter der Autor:innen

fasting glucosegestational diabetes mellitus (GDM)oral glucose tolerance test (OGTT)postpartum diabetes riskrisk stratificationtype 2 diabetes (T2D)

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Institute of Endocrinology, Diabetes and Metabolic Disease, Wolfson Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 58100, Israel.
  • Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
  • Department of Obstetrics and Gynecology, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
  • Department of Internal Medicine A, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
  • Department of Cardiology, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
  • School of Public Health, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

ORCID-Profile: Tal Schiller, Alena Kirzhner

Förderung

  • Marom

Zitieren

APA

Schiller, T., Gabay, L., Barak, O., Kirzhner, A., Abu Khadija, H., Chodick, G., Vaisbuch, E., & Barer, Y. (2026). An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf534

Vancouver

Schiller T, Gabay L, Barak O, Kirzhner A, Abu Khadija H, Chodick G, et al. An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf534

BibTeX
@article{Schiller2026,
  author = {Schiller, Tal and Gabay, Linoy and Barak, Oren and Kirzhner, Alena and Abu Khadija, Haitham and Chodick, Gabriel and Vaisbuch, Edi and Barer, Yael},
  title = {An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf534}
}
Kostenlos starten →